Alteogen Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Alteogen Inc with three other
companies in this sector in KOREA (SOUTH) :
Gene One Life Science Inc
sales of 41.50 billion Korean Won [US$36.56 million]
of which 67%
Cell Biotech Co ., Limited.
(45.58 billion Korean Won [US$40.16 million]
of which 84%
was Finished Products), and
Komipharm International Company Limited
(37.16 billion Korean Won [US$32.74 million]
of which 100%
was Animal Medicine Manufacturing&Sales).
During the first
quarter of 2021, sales at Alteogen Inc totalled
11.88 billion Korean Won .
an increase of 20.3%
from the 9.88 billion Korean Won in sales at the company during the first quarter of 2020.
Alteogen Inc reported sales of 42.43 billion Korean Won (US$37.38 million)
December of 2020.
increase of 45.1%
versus 2019, when the company's sales were 29.23 billion Korean Won .
Sales at Alteogen Inc have increased during each of the previous five years
(and since 2015, sales have increased a total of 798%).